Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ARCB
Valuation Bad
0%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -2.77 1.23 1.26
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 34.61 3.68 2.73
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -0.94 51.90 52.39
Cash -26.54 10.23 13.92
Capex 36.35 -2.49 -3.91
Free Cash Flow 51.82 -2.22 1.46
Revenue -4.26 43.99 45.95
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 23.07 0.07 0.06
Operating Margin -51.07 0.03 0.06
ROA -93.26 < 0.005 0.02
ROE -93.51 < 0.005 0.04
ROIC -58.72 0.01 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ARCB is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ARCB is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ARCB is permitted for members.